Medicared For All Logo

Nasfat Shehadeh MD in Charlotte, North Carolina

Home North Carolina Charlotte

Nasfat Shehadeh MD has Hematology/oncology as his primary medical specialty. Their primary office is: 7108 Pineville Matthews Rd in Charlotte, North Carolina.

They're a part of the: Oncology Specialists Of Charlotte Pa medical group which has around 7 members. You can call their office at 704-342-1900 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 1993 (around 31 years of experience). They are listed as doing telehealth appointments.


Nasfat Shehadeh MD Office Phone and Directions

Nasfat Shehadeh MD
Oncology Specialists Of Charlotte Pa
7108 Pineville Matthews Rd
Charlotte, North Carolina 28226
704-342-1900


Patient Ratings
Please rate your experience with Nasfat Shehadeh MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 704-342-1900


Enter a starting address:


Healthcare Info for Nasfat Shehadeh MD

Additional Medical Specialties Include:
HEMATOLOGY

Medical School: Sorry, his university is not listed
Graduation Year: 1993
The Primary Medical Specialty for Nasfat Shehadeh MD is listed as: Hematology/oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 31
PAC (PECOS ID)#: 4789668534
NPI #: 1538241369
NPI Created On: 10/20/2006
NPI Last Updated Listed as: 11/18/2023
Primary Taxonomy Code: 207RH0003X
License Number:
2015-01740
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Blue Cross Blue Shield
  • Humana
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.


Services and Procedures include:

  1. Insertion of needle into vein for collection of blood sample
  2. Complete blood cell count (red cells, white blood cell, platelets), automated test
  3. New patient office or other outpatient visit, typically 60 minutes
  4. Established patient office or other outpatient, visit typically 25 minutes
  5. Established patient office or other outpatient, visit typically 25 minutes
  6. Established patient office or other outpatient, visit typically 40 minutes
  7. Established patient office or other outpatient, visit typically 40 minutes
  8. Initial hospital inpatient care, typically 70 minutes per day
  9. Subsequent hospital inpatient care, typically 25 minutes per day
  10. Subsequent hospital inpatient care, typically 35 minutes per day

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788360677

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56


Payments Total: $34

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788360679

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56

Drug or Biological #3:: Drug

Product Category #3: Oncology

Name of Drug: ZYTIGA

Name Of Drug #3: 57894-150-12


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788360665

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788360667

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09


Payments Total: $3

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788360669

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788360671

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30


Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788360673

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30


Payments Total: $2

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788360675

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781014947

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28


Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781014949

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28


Hematology/oncology Professionals in Charlotte

1021 Morehead Medical Dr
Charlotte, NC
The Charlotte-mecklenburg Hospital Authority

10320 Mallard Creek Rd
Charlotte, NC
Southern Oncology Specialists Pllc

125 Queens Rd
Charlotte, NC
The Presbyterian Hospital

10905 Providence Rd W
Charlotte, NC
The Presbyterian Hospital

1021 Morehead Medical Dr
Charlotte, NC
The Charlotte-mecklenburg Hospital Authority

10905 Providence Rd W
Charlotte, NC
The Presbyterian Hospital

Providers in Oncology Specialists Of Charlotte Pa

1.Jennifer Dallas

2711 Randolph Rd
Charlotte Nc 28207-2027
Oncology Specialists Of Charlotte Pa
Hematology/oncology

2.Jennifer Dallas

7108 Pineville Matthews Rd
Charlotte Nc 28226-8380
Oncology Specialists Of Charlotte Pa
Hematology/oncology

3.Brooke Davis

2711 Randolph Rd
Charlotte Nc 28207-2027
Oncology Specialists Of Charlotte Pa
Hematology/oncology

4.Brooke Davis

7108 Pineville Matthews Rd
Charlotte Nc 28226-8380
Oncology Specialists Of Charlotte Pa
Hematology/oncology

5.Justin Favaro Md

2711 Randolph Rd
Charlotte Nc 28207-2027
Oncology Specialists Of Charlotte Pa
Hematology/oncology

6.Justin Favaro Md

7108 Pineville Matthews Rd
Charlotte Nc 28226-8380
Oncology Specialists Of Charlotte Pa
Hematology/oncology

View all 7 members of Oncology Specialists Of Charlotte Pa medical group